Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma

Laura R Munro, Peter W. Johnston, Sarah Jane Canning, Mark Adrian Vickers, Neil Andrew Marshall, S. G. Hewitt, K. Tveita

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Genetic factors are known to be important in the development of Hodgkin lymphoma (HL). Interleukin-10 (IL-10) secretion by both malignant and reactive cells is thought to be important in the pathogenesis of HL especially Epstein-Barr virus (EBV) positive cases. Polymorphisms of the IL-10 gene have been reported to be associated with susceptibility to EBV infection. The cytotoxic response to EBV is determined by a Th1 biased immune response which is characterised by interferon gamma (IFNgamma) secretion. We therefore investigated polymorphisms in the IL-10 (-1082 G/A and -592 C/A) and IFNgamma (intron 1 CA repeat) genes as predisposing factors in the development 147 cases of HL. A difference of borderline statistical significance was demonstrated for the IFNgamma gene polymorphism but significance was lost when analysis was restricted to the common genotypes. No significant differences in the distributions of genotypes were found for the IL-10 gene polymorphisms. IL-10 and IFNgamma levels were also measured on 26 patients with HL. No statistically significant differences were detected when the results were analysed by genotype. We found little evidence IL-10 and IFNgamma genotypes predispose to the development of HL or influence the inflammatory host response.

Original languageEnglish
Pages (from-to)2083-2088
Number of pages5
JournalLeukemia & Lymphoma
Volume44
Issue number12
DOIs
Publication statusPublished - 2003

Keywords

  • Hodgkin lymphoma
  • Epstein-Barr virus
  • interleukin-10
  • interferon gamma
  • REED-STERNBERG CELLS
  • BLOOD MONONUCLEAR-CELLS
  • BARR-VIRUS INFECTION
  • B-CELLS
  • DISEASE
  • SUSCEPTIBILITY
  • IL-10
  • REARRANGEMENTS
  • FREQUENCY
  • REPRESENT

Cite this

Munro, L. R., Johnston, P. W., Canning, S. J., Vickers, M. A., Marshall, N. A., Hewitt, S. G., & Tveita, K. (2003). Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma. Leukemia & Lymphoma, 44(12), 2083-2088. https://doi.org/10.1080/1042819031000119316

Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma. / Munro, Laura R; Johnston, Peter W.; Canning, Sarah Jane; Vickers, Mark Adrian; Marshall, Neil Andrew; Hewitt, S. G.; Tveita, K.

In: Leukemia & Lymphoma, Vol. 44, No. 12, 2003, p. 2083-2088.

Research output: Contribution to journalArticle

Munro, LR, Johnston, PW, Canning, SJ, Vickers, MA, Marshall, NA, Hewitt, SG & Tveita, K 2003, 'Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma' Leukemia & Lymphoma, vol. 44, no. 12, pp. 2083-2088. https://doi.org/10.1080/1042819031000119316
Munro, Laura R ; Johnston, Peter W. ; Canning, Sarah Jane ; Vickers, Mark Adrian ; Marshall, Neil Andrew ; Hewitt, S. G. ; Tveita, K. / Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma. In: Leukemia & Lymphoma. 2003 ; Vol. 44, No. 12. pp. 2083-2088.
@article{7af66c4759724f71a94a5496c6eefbfd,
title = "Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma",
abstract = "Genetic factors are known to be important in the development of Hodgkin lymphoma (HL). Interleukin-10 (IL-10) secretion by both malignant and reactive cells is thought to be important in the pathogenesis of HL especially Epstein-Barr virus (EBV) positive cases. Polymorphisms of the IL-10 gene have been reported to be associated with susceptibility to EBV infection. The cytotoxic response to EBV is determined by a Th1 biased immune response which is characterised by interferon gamma (IFNgamma) secretion. We therefore investigated polymorphisms in the IL-10 (-1082 G/A and -592 C/A) and IFNgamma (intron 1 CA repeat) genes as predisposing factors in the development 147 cases of HL. A difference of borderline statistical significance was demonstrated for the IFNgamma gene polymorphism but significance was lost when analysis was restricted to the common genotypes. No significant differences in the distributions of genotypes were found for the IL-10 gene polymorphisms. IL-10 and IFNgamma levels were also measured on 26 patients with HL. No statistically significant differences were detected when the results were analysed by genotype. We found little evidence IL-10 and IFNgamma genotypes predispose to the development of HL or influence the inflammatory host response.",
keywords = "Hodgkin lymphoma, Epstein-Barr virus, interleukin-10, interferon gamma, REED-STERNBERG CELLS, BLOOD MONONUCLEAR-CELLS, BARR-VIRUS INFECTION, B-CELLS, DISEASE, SUSCEPTIBILITY, IL-10, REARRANGEMENTS, FREQUENCY, REPRESENT",
author = "Munro, {Laura R} and Johnston, {Peter W.} and Canning, {Sarah Jane} and Vickers, {Mark Adrian} and Marshall, {Neil Andrew} and Hewitt, {S. G.} and K. Tveita",
year = "2003",
doi = "10.1080/1042819031000119316",
language = "English",
volume = "44",
pages = "2083--2088",
journal = "Leukemia & Lymphoma",
issn = "1042-8194",
publisher = "Informa Healthcare",
number = "12",

}

TY - JOUR

T1 - Polymorphisms in the interleukin-10 and interferon gamma genes in Hodgkin lymphoma

AU - Munro, Laura R

AU - Johnston, Peter W.

AU - Canning, Sarah Jane

AU - Vickers, Mark Adrian

AU - Marshall, Neil Andrew

AU - Hewitt, S. G.

AU - Tveita, K.

PY - 2003

Y1 - 2003

N2 - Genetic factors are known to be important in the development of Hodgkin lymphoma (HL). Interleukin-10 (IL-10) secretion by both malignant and reactive cells is thought to be important in the pathogenesis of HL especially Epstein-Barr virus (EBV) positive cases. Polymorphisms of the IL-10 gene have been reported to be associated with susceptibility to EBV infection. The cytotoxic response to EBV is determined by a Th1 biased immune response which is characterised by interferon gamma (IFNgamma) secretion. We therefore investigated polymorphisms in the IL-10 (-1082 G/A and -592 C/A) and IFNgamma (intron 1 CA repeat) genes as predisposing factors in the development 147 cases of HL. A difference of borderline statistical significance was demonstrated for the IFNgamma gene polymorphism but significance was lost when analysis was restricted to the common genotypes. No significant differences in the distributions of genotypes were found for the IL-10 gene polymorphisms. IL-10 and IFNgamma levels were also measured on 26 patients with HL. No statistically significant differences were detected when the results were analysed by genotype. We found little evidence IL-10 and IFNgamma genotypes predispose to the development of HL or influence the inflammatory host response.

AB - Genetic factors are known to be important in the development of Hodgkin lymphoma (HL). Interleukin-10 (IL-10) secretion by both malignant and reactive cells is thought to be important in the pathogenesis of HL especially Epstein-Barr virus (EBV) positive cases. Polymorphisms of the IL-10 gene have been reported to be associated with susceptibility to EBV infection. The cytotoxic response to EBV is determined by a Th1 biased immune response which is characterised by interferon gamma (IFNgamma) secretion. We therefore investigated polymorphisms in the IL-10 (-1082 G/A and -592 C/A) and IFNgamma (intron 1 CA repeat) genes as predisposing factors in the development 147 cases of HL. A difference of borderline statistical significance was demonstrated for the IFNgamma gene polymorphism but significance was lost when analysis was restricted to the common genotypes. No significant differences in the distributions of genotypes were found for the IL-10 gene polymorphisms. IL-10 and IFNgamma levels were also measured on 26 patients with HL. No statistically significant differences were detected when the results were analysed by genotype. We found little evidence IL-10 and IFNgamma genotypes predispose to the development of HL or influence the inflammatory host response.

KW - Hodgkin lymphoma

KW - Epstein-Barr virus

KW - interleukin-10

KW - interferon gamma

KW - REED-STERNBERG CELLS

KW - BLOOD MONONUCLEAR-CELLS

KW - BARR-VIRUS INFECTION

KW - B-CELLS

KW - DISEASE

KW - SUSCEPTIBILITY

KW - IL-10

KW - REARRANGEMENTS

KW - FREQUENCY

KW - REPRESENT

U2 - 10.1080/1042819031000119316

DO - 10.1080/1042819031000119316

M3 - Article

VL - 44

SP - 2083

EP - 2088

JO - Leukemia & Lymphoma

JF - Leukemia & Lymphoma

SN - 1042-8194

IS - 12

ER -